• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

IRS ruling: Allergan director leaves board to remain at AMO

Article

Irvine, CA-William R. Grant has retired as a director of Allergan Inc. to fulfill Internal Revenue Service requirements that prohibit him from also serving as a director of Advanced Medical Optics (AMO) for more than 1 year after Allergan spun it off.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.